DK4346847T3 - Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation - Google Patents
Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammationInfo
- Publication number
- DK4346847T3 DK4346847T3 DK22732150.2T DK22732150T DK4346847T3 DK 4346847 T3 DK4346847 T3 DK 4346847T3 DK 22732150 T DK22732150 T DK 22732150T DK 4346847 T3 DK4346847 T3 DK 4346847T3
- Authority
- DK
- Denmark
- Prior art keywords
- pluri
- prevention
- treatment
- ionic complex
- neurogenic inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE20215448A BE1029458B1 (fr) | 2021-06-04 | 2021-06-04 | Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation neurogène |
| PCT/EP2022/065271 WO2022254042A1 (en) | 2021-06-04 | 2022-06-03 | Pluri-ionic complex for the prevention or treatment of neurogenic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4346847T3 true DK4346847T3 (da) | 2025-10-20 |
Family
ID=76325316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22732150.2T DK4346847T3 (da) | 2021-06-04 | 2022-06-03 | Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240261323A1 (da) |
| EP (1) | EP4346847B1 (da) |
| JP (1) | JP2024520753A (da) |
| CN (1) | CN117479948A (da) |
| BE (1) | BE1029458B1 (da) |
| DK (1) | DK4346847T3 (da) |
| ES (1) | ES3047741T3 (da) |
| PL (1) | PL4346847T3 (da) |
| PT (1) | PT4346847T (da) |
| WO (1) | WO2022254042A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1030588B1 (fr) * | 2022-06-03 | 2024-01-08 | Ynios Pharma | Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639625A (en) * | 1967-07-13 | 1972-02-01 | Lewis Sherwin | Compositions containing lithium succinate |
| US5516534A (en) * | 1993-11-26 | 1996-05-14 | Rensselaer Polytechnic Institute | Composition and method for reducing structural defects |
| US6572902B2 (en) * | 2001-04-25 | 2003-06-03 | Advanced H2O, Inc. | Process for producing improved alkaline drinking water and the product produced thereby |
| CA2730009C (en) * | 2007-07-12 | 2017-08-15 | Whipbird Pain Relief Pty Ltd. | Topical medicament |
| AU2008274908B2 (en) * | 2008-07-11 | 2014-08-14 | Whipbird Pain Relief Pty Ltd | Topical medicament |
| HUE056696T2 (hu) * | 2008-12-09 | 2022-03-28 | Warburton Technology Ltd | Nyomelemek |
| KR100943204B1 (ko) * | 2009-07-14 | 2010-02-19 | 주식회사메자이텍 | 혈액순환 개선용 기능성 음용수 및 이의 제조방법 |
| KR101326472B1 (ko) * | 2011-11-28 | 2013-11-08 | 가톨릭대학교 산학협력단 | 광천수를 함유한 비강 세척용 조성물 |
| CN108310287A (zh) * | 2018-04-26 | 2018-07-24 | 深圳安济堂医药科技有限公司 | 治疗癌症的口服液及其制备方法 |
| KR102187895B1 (ko) * | 2019-03-12 | 2020-12-07 | 가톨릭대학교 산학협력단 | 대사성 질환의 예방 또는 치료용 조성물 |
-
2021
- 2021-06-04 BE BE20215448A patent/BE1029458B1/fr not_active IP Right Cessation
-
2022
- 2022-06-03 PL PL22732150.2T patent/PL4346847T3/pl unknown
- 2022-06-03 JP JP2023575390A patent/JP2024520753A/ja active Pending
- 2022-06-03 PT PT227321502T patent/PT4346847T/pt unknown
- 2022-06-03 WO PCT/EP2022/065271 patent/WO2022254042A1/en not_active Ceased
- 2022-06-03 EP EP22732150.2A patent/EP4346847B1/en active Active
- 2022-06-03 ES ES22732150T patent/ES3047741T3/es active Active
- 2022-06-03 CN CN202280040005.XA patent/CN117479948A/zh active Pending
- 2022-06-03 US US18/566,954 patent/US20240261323A1/en active Pending
- 2022-06-03 DK DK22732150.2T patent/DK4346847T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| BE1029458B1 (fr) | 2023-01-09 |
| EP4346847A1 (en) | 2024-04-10 |
| US20240261323A1 (en) | 2024-08-08 |
| EP4346847B1 (en) | 2025-09-17 |
| PL4346847T3 (pl) | 2025-12-01 |
| BE1029458A1 (fr) | 2023-01-05 |
| JP2024520753A (ja) | 2024-05-24 |
| PT4346847T (pt) | 2025-10-23 |
| ES3047741T3 (en) | 2025-12-04 |
| CN117479948A (zh) | 2024-01-30 |
| WO2022254042A1 (en) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3860990T3 (da) | Inhibitorer for YAP/TAZ-TEAD interaktion og disses anvendelse ved behandlingen af cancer | |
| DK4014976T3 (da) | Aprocitentan til anvendelse i behandlingen af hypertension og relaterede sygdomme i kombination med valsartan | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3713554T3 (da) | Doseringsanvisninger for vidofludimus til behandling af kroniske inflammatoriske og/eller autoimmunsygdomme | |
| DK3806898T3 (da) | Gremlin-1-antagonist til anvendelse i behandling af cancer | |
| DK4327866T3 (da) | Mirikizumab ved behandling af ulcerøs kolitis | |
| DK3972643T3 (da) | Komplementsystemantagonister til anvendelse i fremgangsmåder til behandling af paraproteinemiske neuropatier | |
| DK3962601T3 (da) | 5-HT2A-agonister til anvendelse til behandling af depression | |
| DK3982924T3 (da) | Planteekstraktblanding til anvendelse ved forebyggelse og/eller behandling af kroniske inflammatoriske tarmsygdomme | |
| DK3432899T3 (da) | Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis | |
| DK3247352T3 (da) | Cebranopadol til behandling af smerter hos individer med forringet lever- og/eller forringet nyrefunktion | |
| DK3362449T3 (da) | Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose | |
| MA49248A (fr) | Inhibiteurs de fgfr2 utilisés dans le traitement du cholangiocarcinome | |
| DK3570940T3 (da) | Pridopidin til anvendelse i behandling af fragilt x-syndrom | |
| DK4005570T3 (da) | Pridopidin til anvendelse behandling af retts syndroe | |
| DK3442547T3 (da) | Lactobacillus reuteri MM4-1A til anvendelse i behandling eller forebyggelse af autismespektrumforstyrrelser | |
| DK3522904T3 (da) | Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux | |
| DK3592355T3 (da) | KX2-391/KX-01 til anvendelse i behandling af aktinisk keratose | |
| IL270978B (en) | Grape skin for use in the treatment of dysbiosis | |
| DK3866772T3 (da) | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-dien-1,4-dion til undertrykkelse og behandling af alpha-synucleinopathier, tauopathier og andre lidelser | |
| DK3519411T3 (da) | Heterocykliske forbindelser og deres anvendelse inden for forebyggelsen eller behandlingen af bakterieinfektioner | |
| DK4419526T3 (da) | Heterocykliske forbindelser til anvendelse i behandlingen af cancer | |
| DK3506900T3 (da) | Ampreloxetin til anvendelse i behandlingen af neurogen ortostatisk hypotension | |
| DK3373922T3 (da) | Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri | |
| DK4346847T3 (da) | Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation |